Showing results (31-40 of 415) with videos related to
Sort By:
Pageof 42
Cell Cycle (Georgetown, Tex.)|March 17, 2004
Oncogenic K-ras in mouse models of myeloproliferative disease and acute myeloid leukemiaIris T Chan, D Gary GillilandCurrent Opinion in Hematology|November 30, 2006
JAK-2 mutations and their relevance to myeloproliferative diseaseRoss L Levine, D Gary GillilandCurrent Opinion in Genetics & Development|January 9, 2007
Jak2: normal function and role in hematopoietic disordersJames N Ihle, D Gary GillilandAnnual Review of Medicine|October 9, 2007
A role for JAK2 mutations in myeloproliferative diseasesKelly J Morgan, D Gary GillilandBlood|August 15, 2002
The roles of FLT3 in hematopoiesis and leukemiaD Gary Gilliland, James D GriffinBest Practice & Research. Clinical Haematology|March 18, 2008
Can FLT3 inhibitors overcome resistance in AML?Winnie F Tam, D Gary GillilandNature Reviews. Clinical Oncology|February 29, 2012
Drug development and clinical trials--the path to an approved cancer drugEric H Rubin, D Gary GillilandJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
The role of signal transducer and activator of transcription factors in leukemogenesisDavid W Sternberg, D Gary GillilandPageof 42